Arthropod-borne Viral Infections Testing Market

2019 Analysis and Review of Arthropod-borne Viral Infections Testing Market by Test Type - ELISA-based Tests, RT-PCR-based Tests, and Immunochromatography Rapid Diagnosis for 2019-2029

  • 2020-05-11
  • REP-GB-11572
  • 24 Tables
  • 146 Figures
  • 206 pages
  • PDF PPT EXCEL
Arthropod-borne Viral Infections Testing Market
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

Arthropod-borne Viral Infections Testing Market Size to Expand 1.7X by 2029

The world, in recent decades, has witnessed the contagion of prominent epidemics caused by viral agents or zoonotic viruses, with Arthropod-borne viruses responsible for a majority of epidemics. At present, Arthropod-borne viral infections are rapidly emerging, especially in developing and under-developed regions, wherein, factors such as lack of awareness and lax government norms are responsible for the spread of infections. In an effort to contain the spread, governments across the world are swiftly approving testing methods to contain Arthropod-borne viral infections. Over the forecast period, 2019-2029, the global Arthropod-borne viral infections testing market will surge nearly 1.7X. 

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Report Scope

Report Metrics

Details

Base year considered

2019

Actual estimates/Historical data

2014- 2018

Forecast period

2019- 2029

Forecast units

Value (USD) Mn

Segments covered

Test Type, End User, and Region

Regions covered

North America (US & Canada), Western Europe (UK, Germany, France, Spain, Italy, Rest of Western Europe), Eastern Europe( Russia & Rest of Eastern Europe), Latin America (Brazil, Mexico, and  Rest of LA), APEJ (China, India, A&NZ and Rest of APEJ), and MEA (GCC, South Africa, and Rest of MEA)

Key Players

Thermo Fisher Scientific, Inc, Roche Molecular Systems Inc., bioMérieux SA, Abbott Laboratories, InBios International, Inc., NovaTec Immundiagnostica GmbH, Euroimmun AG (Sub. PerkinElmer), Quest Diagnostics, Certest Biotec S.L., Response Biomedical Corp, and Chembio Diagnostic Systems Inc.

Report coverage

Revenue forecasts, competitive landscape, growth factors, and trends

Arthropod-borne Viral Infections Testing Market - Key Research Findings

  1. By 2029, the Arthropod-borne viral infections testing market size will reach around US$ 2 Bn.
  2. The Arthropod-borne viral infections testing market is anticipated to expand at a CAGR of 6% during the forecast period of 2019-2029.
  3. ELISA-based tests would be the preferred test type in the Arthropod-borne viral infections testing market.
    • Growth of this particular segment can be primarily attributed to the rising interest and acceptance of ELISA-based test diagnostics in developing countries.
  4. Latin America is stipulated to account for around 21% of the global Arthropod-borne viral infections testing market revenue by 2029.
    • The Latin America market continues to offer lucrative prospects to Arthropod-borne viral infections testing providers, given the increasing Arthropod-borne viral infections and testing techniques used in healthcare institutions for providing quality care. This has further resulted in increased adoption of molecular-based techniques such as ELISA and RT-PCR.
  5. Public healthcare laboratories will remain the prominent end-use category in the Arthropod-borne viral infections testing market.
    • Increasing access to advanced healthcare in developed public healthcare laboratories employing advanced molecular techniques for quick detection of Arthropod-borne viral pathogens is among the major factors propelling the Arthropod-borne viral infections testing market.

Key Factors Shaping Arthropod-borne Viral Infections Testing Market

Re-emergence of Arthropod-borne Viral Infections 

  • Disordered urban growth, environmental changes due to changing lifestyle, and globalization are major causes of the dissemination and emergence of Arthropod-borne viral infections.
  • Reemergence of the viral infection has caused widespread epidemics of human and animal diseases, making them more unpredictable. This has resulted in sporadic outbreaks in Latin America.
    • For instance, Brazilian national authorities estimate that, between 497,593 and 1,482,701 cases of Zika virus infections have been reported since the outbreak. After Brazil, Colombia has been the most-affected country so far, with 20,297 cases reported (Jan 2016) since the country’s first case detected in October 2015.

Integrated Government Initiatives

Arboviruses are an emerging threat in Europe. Rising infection rates driven by increasing global trade and travel has fueled the adoption of Arthropod-borne viral infections testing in new geographies.

  • Because of the increasing threat, the European Centre for Disease Prevention and Control (ECDC) started an integrated control strategy against invasive Arthropod-borne vectors, with coordinated involvement of local authorities, private partners, and organized societies.
  • This initiative mainly focuses on public education, vector control, and period diagnosis in infection prone areas.
  • ECDC also provides vector distribution maps and step-by-step guidelines for the surveillance of invasive mosquitos, to raise awareness among the population.

In a bid to break the pattern of the coronavirus (COVID-19) pandemic across the globe, governments are showing immediacy in approving diagnostic tests to treat affected patients. A majority of these tests are based on enzyme-linked immunosorbent assays (ELISA) - that offer faster results - and reverse transcription polymerase chain reaction (RT-PCR) - the current standard approach for COVID-19. Increasing cases and uncertainties regarding COVID-19 have offered an additional wave of growth to players in the Arthropod-borne viral infections testing market.

Arthropod-borne Viral Infections Testing Market: Completion Analysis

  • The Arthropod-borne viral infections testing market is highly competitive. Approximately 10 Arthropod-borne viral infections testing providers are present globally. Tier-1 players lead the market with around 50% revenue share.
  • In high-impact markets such as Latin America, East Asia, and South Asia, there are stringent regulations for the approval of Arthropod-borne viral infections testing procedures. However, incumbents developing new testing methods will help achieve regulatory compliance rapidly. These tests have already been made operational in low-risk regions in the US, Canada, and some nations in Europe. Such developments will help in facilitating secure exchange ideas for product development, and thus, protect overall patient safety and other challenges.
  • Some of the key players are mainly focused on developing diagnostics based on microarray technology. The technology majorly consists of detecting nucleic acid fragments of different pathogens.
    • Some the leading players in the Arthropod-borne viral infections testing market are Thermo Fisher Scientific, Inc, Roche Molecular Systems Inc., bioMérieux SA, and Abbott Laboratories
  • Arthropod-borne viral infections testing market players are also focused on emerging markets such as India, China, and Brazil, owing to their significant marketing network of distributors. Moreover, due to strategic partnerships and tie-ups with local sales bodies and the presence of international offices in other regions, major players could deliver their services and solution offerings to retain their customer base.

Arthropod-borne Viral Infections Testing Market Analysis by Test Type

Enzyme-linked immunosorbent assay (ELISA)-based tests are considered a preferred laboratory tool among researchers and professionals in sectors such as healthcare, life sciences, and industries, as the testing method is sensitive, specific, economical, and reliable. By 2029, realization from ELIS-based tests would reach near US$ 1 Bn. The autoimmunity immunoassay field is transforming, and in the recent past, the development of no wash ELISAs, reduced assay step protocols, and new automated systems designed to run ELISA-based tests have entered the laboratories. Moving forward, healthcare diagnostic testing market players will also capitalize on reverse-transcription polymerase chain reaction (RT-PCR) kits, owing to their better turnaround time (3-4 hours).

Arthropod-borne Viral Infections Testing Market Regional Assessment

The Middle East & Africa (MEA) and Latin America would remain the epicenter of value-creation opportunities. While both these regions share almost equal divide in the global Arthropod-borne viral infections testing market, players would cite MEA for substantial profits. Alarmed by the expanding patient pool of Arthropod-borne viral infections, governments in MEA and Latin America are increasingly spending on the healthcare industry in order to deliver quality-focused care. Going forward, the Asia Arthropod-borne viral infections testing market will also offer potential revenue lines to investors. 

* This data is only a representation. Actual data may vary and will be available in report.

Arthropod-borne Viral Infections Testing Market Regional Assessment
Arthropod-borne Viral Infections Testing Market Regional Assessment
Arthropod-borne Viral Infections Testing Market Regional Assessment
Arthropod-borne Viral Infections Testing Market Regional Assessment
  • 2014
  • 2018
  • 2022
  • 2029
  • Arrow

Government-backed Initiatives to Augur Well for Market Growth

Arboviruses are considered an emerging threat across several regions, worldwide. Rise in global trade and travel activities are responsible for the emergence of Arthropod-borne viral infections in new geographies. Alerted by the possible threat, government agencies such as the European Centre for Disease Prevention and Control (ECDC) have initiated the integrated control strategy against invasive Arthropod-borne vectors with the coordinated involvement of local authorities, private partners, and organized societies. The initiative is primarily focused on vector control, public education, and period diagnosis in infectioniprone regions. In addition, ECDC offers vector distribution maps and guidelines for the surveillance of invasive mosquitos to raise awareness among demographics. Such government-backed initiatives will drive the growth of the Arthropod-borne viral infections testing market. 

High preference for ELISA-based tests

RT-PCR based tests to gain traction

Public health laboratories remain key end user

Diagnostic centres to offer growth avenues

How Growth will Unfold

Public healthcare laboratories would remain the primary end user of Arthropod-borne viral infections testing, owing to increasing investments in advanced healthcare equipped with viral molecular diagnostic techniques. Capturing around one-third of overall market value, market players continue to allocate their resources to public healthcare laboratories. On the other hand, diagnostic centers are also attracting stakeholders’ investments. While both, public healthcare laboratories and diagnostic centers exhibit similar CAGRs, the former would remain a key revenue pocket.

Arthropod-borne Viral Infections Testing Market by End User

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Custom Market Research Services

FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Overview

A recent market study published by Future Market Insights on the Arthropod-borne viral infections testing market includes global industry analysis of 2014-2018 and opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the market, growth prospects of the market are obtained with maximum precision.

Arthropod-borne Viral Infections Testing Market Taxonomy

The global Arthropod-borne viral infections testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.

Test Type

  • ELISA-based Tests
  • RT-PCR-based Tests
  • Immunochromatography Rapid Diagnosis

End User

  • Hospitals
  • Public Health Laboratories
  • Diagnostic Centers
  • Others

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

What's Included

The report initiates with the executive summary of the Arthropod-borne viral infections testing market, which includes a summary of the key findings and statistics of the market. It also includes supply-side and demand-side trends pertaining to the Arthropod-borne viral infections testing Market.

Readers can find the definition and a detailed segmentation of the Arthropod-borne viral infections testing market in this chapter, which will help them understand the basic information about the market. Along with this, comprehensive information pertaining to the types of Arthropod-borne viral infections testing components and their features are provided in this section.This section also explains the global Arthropod-borne viral infections testing market value analysis and forecasts for the market during the forecast period. This chapter includes a detailed analysis of the historical market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2029). Information about the drivers, restraints, and trends of the Arthropod-borne viral infections testing market are included. This section also includes the macroeconomic factors and various opportunities of the Arthropod-borne viral infections testing market.

This section explains the arthropod-borne viral infections testing market volume analysis and forecasts for the market for the forecast period of 2019-2029.

This section highlights the global arthropod-borne viral infections testing market pricing analysis. This section helps the readers to understand the pricing variation of Arthropod-borne viral infections testing in terms of diagnostic testing in various geographies.

This section explains the global Arthropod-borne viral infections testing market value analysis and forecasts for the market during the forecast period. This chapter includes a detailed analysis of the historical market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2029).

This section gives information about drivers and restraints of the Arthropod-borne viral infections testing market. This section also includes the macroeconomic factors and various opportunities of the market.

Based on test type, the Arthropod-borne viral infections testing market is segmented into ELISA-based tests, RT-PCR-based tests, and immunochromatography rapid diagnosis. In this chapter, readers can find information about Y-o-Y growth and market attractiveness analysis based on test type.

Based on end user, the Arthropod-borne viral infections testing market is segmented into hospitals, public health laboratories, diagnostic centers, and others. In this chapter, readers can understand the Y-o-Y growth and market attractiveness analysis based on end user.

This chapter explains how the Arthropod-borne viral infections testing market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa.

This chapter includes a detailed analysis of growth of the North America Arthropod-borne viral infections testing market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on test type, end user, and countries in North America.

This chapter provides the growth scenario of the Arthropod-borne viral infections testing market in Latin American countries such as Brazil, Mexico, Argentina, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Important growth prospects of the Arthropod-borne viral infections testing market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, BENELUX, Russia, and the Rest of Europe are included in this chapter.

Important growth prospects of the Arthropod-borne viral infections testing market across target segments in several countries such as China, Japan, and South Korea are included in this chapter.

In this chapter, India, Indonesia, Thailand, and Malaysia are prominent countries in the South Asia region. Readers can find detailed information about the growth parameters of the South Asia market during the forecast period of 2019-2029.

This section highlights the growth prospects of the Arthropod-borne viral infections testing market for Australia and New Zealand, during the forecast period of 2019-2029.

This chapter provides information about how the Arthropod-borne viral infections testing market will grow in major countries in the MEA region, such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in Arthropod-borne viral infections testing market.

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the Arthropod-borne viral infections testing market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured are Thermo Fisher Scientific, Inc, Roche Molecular Systems Inc., bioMérieux SA, Abbott Laboratories, InBios International, Inc., NovaTec Immundiagnostica GmbH, Euroimmun AG (Sub. PerkinElmer), Quest Diagnostics, Certest Biotec S.L., Response Biomedical Corp, and Chembio Diagnostic Systems, Inc.

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the Arthropod-borne viral infections testing market report.

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the Arthropod-borne viral infections testing market.

How the research was conducted?

Primary Research

  • C - Level Executives
  • Service Representatives
  • Sales Heads
  • Portfolio Managers
  • Purchasing Managers
  • Researchers & Academicians 
  • Service Development Heads
  • Strategy Advisors
  • R&D Managers
  • Service Providers
  • Distributors
  • Institute Purchasing Departments
  • Academicians / Contract Manufacturing Managers
  • Industry Experts

Secondary Research

  • Industry Magazines 
  • Factiva
    • Industry Associations
    • International Arthpod-Borne Viral Infections Consortium
    • American Society of Virology 
  • Industry Publications
    • Frontiers Publication
    • Hindawi BioMed Research International
    • Taylor & Francis
  • Company Press Releases
  • Annual Reports and Investor Presentations
  • Peer-reviewed Journals
  • Government Websites and Publications
  • Trade Websites
  • Country-specific Regulatory Authorities
  • World Bank, WHO, IMF, OECD

Primary Interview Splits

Primary Interview Splits Arthropod borne viral infections testing market designation

Primary Interview Splits Arthropod borne viral infections testing market stakeholder

To Learn More About our Comprehensive Perspective on Arthropod-borne Viral Infections Testing Market,

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology